Safe Medicines for Animals-regulatory training (SMArt): Annual Report and Accounts 2024 2025 ## A. Charity details. - 1.Registered as a CIO-Foundation November 1[st] , 2019. - 2.Charity number- 1186100. - 3.Trustees and secretary: - a. Professor A. R. Peters (Chair from 18/4/23). - b. Professor S.P. Borriello CB. - c. Dr. L.W. Muraguri. - d. Mr. D. Corner. ## 4.Bank: The Co-operative bank (Community Directplus Account established 11/05/21). Co-Operative Bank plc., PO Box 50, Skelmersdale, WN8 6YL. 5. Structure, Governance and Management. The charity is established as a Foundation model Charitable Incorporated Organisation (CIO), whose only voting members are the charity trustees (see A3 a-e above). ## B. Charitable Purpose. The preservation and protection of public health and the prevention of suffering of animals by the provision of education and training in the safe and effective use of veterinary medicines for the agricultural community in developing nations, so that dangerous substances do not enter the food chain and in the process endanger the health of both humans and animals. ## C. Charitable Objectives. To be a global partner for low- and middle-income countries in the provision of education, development and training for the safe, responsible and effective use of veterinary medicines and its subsequent benefit to environmental, animal and human welfare, and economic development. ## D. Lay Description. Just like people, animals can become ill and require treatment with medicines. These animals include working and companion animals, and animals raised as livestock (including bees and farmed fish), zoo/safari animals, and on occasion, wild animals. Also, as in people, medicines have to be specifically developed, doses recommended, and then be authorised by an independent Government body (a medicines regulator) to ensure they will work as expected, be safe to the animals, people who eat meat and dairy produce, and to the environment (as some will be excreted by the animal). This regulatory process is very exacting. Once medicines are marketed there also has to be a process to monitor for adverse events (side-effects or failure to work properly), and processes to inspect the manufacturers, and the distribution chain, of the medicines. The charity is dedicated to ensuring the availability of support, training and improved processes to those countries where the regulatory processes are not yet fully mature. E. Activities of the Charity. To maximise awareness by stakeholders and other interested parties of progress on co-ordination of regulatory activities in sub-Sahara Africa and of outstanding needs, one of us (SPB) co-authored a paper on this topic [ Pyatt AZ. et al (2025). Veterinary Medicinal Product Regulation in sub-Sahara Africa: Identifying Barriers and Opportunities for Enhancing VMP Regulatory Systems. Front. Vet. Sci. 12:1532098. doi: 10.3389/fvets.2025.1532098]. To provide further assurance on the activities of regulators, particularly those in low- and middle-income countries, one of us (SPB) co-authored a paper on development of a suitable self-assessment/benchmarking tool [ Joseph N. et al. (2025) development of a Self-Assessment/Benchmarking Tool for regulators of Veterinary Medicines. Front. Vet. Sci. 12:1648556. Doi: 10.3389/fvets.2025.1648556]. The key risk remains as the absence of funds and the continuing lack of administrative support, due to The Bill and Melinda Gates Foundation decision to continue funding of improvement of veterinary Medicines regulation in sub-Sahara Africa through the charity GalvMed, instead of using the Veterinary Medicines Directorate as Principal Investigator, thereby removing the need for SMArt to be a holder of funds. SMArt now needs to consider change of charitable status to reflect better the likely sums of funds it may be able to secure, or to dissolve the charity. These decisions will be taken by the Trustees during 2026. F. Statement of Financial Activities and Balance Sheet. (i) The charity did not receive any funding for the reporting period. (ii)The charity had no expenditure for the reporting period. (iv)There is no entitled/certain to receive income for 2/5/23-1/5/244 (v)There were no trustee renumerations or related party transactions. Trustee meetings were either virtual or, when face –to-face, arranged for occasions when trustees were in the same locality for another primary purpose. STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 2/5/23. 2024-25 2023-24 2022-23 1. Incoming Resources 1.1 Donations £0 £0 £530 - 1.2 Other £0 £0 £0 Total £0 £0 £530 2.Resources Expended £0 £0 £0 3. Reconciliation of Funds 3.1 Funds brought £530 £530 £0 forward - - 4. Total Funds Carried £530 £530 £530 - Forward BALANCE SHEET AS OF 2/5/23 2024-25 2023-24 2022-23 202122 1. Fixed Assets - - - 2. Current Assets 2.1 Cash in bank £530 £530 £530 3. Total Assets £530 £530 £530 - G. This report was prepared by S. P. Borriello CB (Trustee).